This compound is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). Its structure, featuring a Boc-protected amine and a fluorophenyl group, makes it a valuable intermediate in organic synthesis. It is often employed in the preparation of compounds targeting neurological disorders, such as antidepressants and anxiolytics, due to the presence of the fluorophenyl moiety, which can enhance binding affinity to certain receptors. Additionally, the Boc group serves as a protective strategy for the amine functionality during multi-step synthetic processes, ensuring selective reactions. Its application extends to the production of peptidomimetics and other biologically active molecules, where precise control over functional groups is critical.